You searched for "proptosis"
Timing of vitrectomy for retained lens fragments
1 February 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
The purpose of this study was to compare the results of same setting vitrectomy with delayed vitrectomy for retained lens fragments following cataract surgery. Same setting vitrectomy was defined as the patient not leaving the operating table following cataract surgery....
VKH outcomes with pulse IV steroids
1 April 2019
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a retrospective review of clinical case notes records of 111 Vogt-Koyanagi-Harada (VKH) patients between 1999 and 2015 from a single centre in Tokyo, Japan. The mean age at presentation was 41 years and the median follow-up period was...
G-CSF intravitreal injections for NAION: a pilot study
5 April 2022
| Su Young
|
EYE - Neuro-ophthalmology
|
Anterior ischemic optic neuropathy, Granulocyte colony-stimulating factor, Intravitreal injection, Neuroprotection, Optic atrophy
In rodent models with anterior ischemic optic neuropathy (AION), granulocyte colony-stimulating factor (G-CSF) confers a neuroprotective effect on retinal ganglion cells (RGCs) via anti-apoptotic and anti-inflammatory processes. This prospective study investigated the efficacy of intravitreal injection of G-CSF for the...
Insights from the ‘Rb-NET Challenges’ Session: Evolving approaches in global retinoblastoma management
2 April 2025
| Mattan Arazi, Ido Didi Fabian, Nick Astbury, Brenda Gallie (Prof), Covadonga Bascaran, Marcia Zondervan
|
EYE - Paediatrics, EYE - Pathology, EYE - Oncology
The Retinoblastoma Network (Rb-NET) Multidisciplinary Team (MDT) platform, developed by the London School of Hygiene & Tropical Medicine (LSHTM) and Professor Ido Didi Fabian, is a web-based telemedicine initiative that regularly hosts virtual MDT meetings focused on the evaluation and...
Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)
3 April 2023
| Li Yen Goh
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...
Development of testing protocols for high and low contrast visual acuity
1 April 2018
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Amyotrophic lateral sclerosis, LCD tablet, high-contrast visual acuity, low-contrast visual acuity, pinhole
Dysfunction of the afferent visual system, characterised by impairments in high-contrast visual acuity (HCVA) and low-contrast visual acuity (LCVA) have been demonstrated in some neurological conditions such as multiple sclerosis and Parkinson’s disease. HCVA and LCVA are also potential quantitative...
Moorfields surgeons save the sight of 24 wounded Bangladeshi students
Moorfields Eye Hospital consultant ophthalmologists Mahi Muqit and Niaz Islam were invited to Dhaka by Bangladesh’s interim government to help 120 patients with bullet wounds to their eyes. Their injuries were a result of their involvement in protests against the...
Fingolimod: ocular adverse effects
1 October 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
An update on inherited retinal disorders (part 1) – overview and assessment of inherited retinal disease
1 October 2016
| Michel Michaelides (Prof)
|
EYE - Vitreo-Retinal
Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....
Innovations in ophthalmology: what can the innovations of the past teach us about tomorrow?
BUOS Prize Essay – 2nd prize winner for 2013 submissions Introduction An essay titled Innovations in Ophthalmology might choose to focus on the history; from cataract couching to femtosecond lasers, ophthalmology has had no shortage of topics worthy of discussion....The past and the future for paediatric ophthalmology
1 June 2018
| Jane Ashworth, Chris Lloyd (Prof)
|
EYE - Paediatrics
The past 25 years have seen remarkable advances in clinical eye care for children in the UK. This has led to both improved outcomes and better patient and family experiences. There have been substantial changes to patient pathways, major advances...
Treatment options for septic cavernous sinus thrombosis
1 April 2017
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Cavernous sinus thrombosis, infection, treatment
Septic cavernous sinus thrombosis is a rare but serious complication of infection of the cavernous sinuses. Potential therapies include antibiotics, corticosteroids and anticoagulation, as well as surgical intervention for source control of the infection. The authors report that there is...
